Imunon, Inc.
Nasdaq: IMNNPharmaceutical Preparations · Entity-resolved by Clous
CIK0000749647
TickerIMNN
ExchangeNasdaq
SIC2834
StateDE
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
RevenueFY2023-12-31
$500K
+0.0% YoY
Net IncomeFY2025-12-31
-$14.5M
+22.2% YoY
Total AssetsFY2025-12-31
$12.29M
+26.5% YoY
EquityFY2025-12-31
$7.06M
+66.4% YoY
Shares OutstandingFY2025-12-31
3.92M
—
Operating Cash FlowFY2025-12-31
-$13.9M
+26.3% YoY
Short interest & fails
Cost to borrow12.59%100K shares availablehard to borrow
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $500K | $500K | — | — | — | — |
| Net Income | -$35.9M | -$19.51M | -$18.62M | -$14.5M | +22.2% | — |
| Total Assets | $43.98M | $21.92M | $9.72M | $12.29M | +26.5% | — |
| Equity | $29.33M | $13.39M | $4.24M | $7.06M | +66.4% | — |
| Operating Cash Flow | -$23.13M | -$19.02M | -$18.85M | -$13.9M | +26.3% | — |
| Shares Outstanding | — | — | — | 3.92M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0000749647